retatrutide legal Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial Is Retatrutide Safe for Women?

No supplement replaces foundational health habits

GLP1s may offer midlife women other benefits besides weight loss

Schedule a consultation to create a personalized plan for facial and body rejuvenation after weight loss.

Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point

The Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial was conducted to investigate the impact of adding semaglutide to standard care on the risk of major adverse cardiac events (MACE) among overweight or obese non-diabetic patients with preexisting CVD